Compare PTGX & UPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTGX | UPST |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.8B |
| IPO Year | 2016 | 2020 |
| Metric | PTGX | UPST |
|---|---|---|
| Price | $82.46 | $50.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $93.00 | $59.96 |
| AVG Volume (30 Days) | 909.6K | ★ 5.0M |
| Earning Date | 02-20-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | 0.26 |
| Revenue | $209,217,000.00 | ★ $997,748,000.00 |
| Revenue This Year | N/A | $56.14 |
| Revenue Next Year | $288.98 | $22.99 |
| P/E Ratio | ★ $114.23 | $197.57 |
| Revenue Growth | N/A | ★ 64.93 |
| 52 Week Low | $33.70 | $31.40 |
| 52 Week High | $96.54 | $96.43 |
| Indicator | PTGX | UPST |
|---|---|---|
| Relative Strength Index (RSI) | 35.78 | 59.59 |
| Support Level | $84.11 | $43.06 |
| Resistance Level | $89.61 | $52.10 |
| Average True Range (ATR) | 3.13 | 2.39 |
| MACD | -1.11 | 0.28 |
| Stochastic Oscillator | 19.24 | 81.92 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. Upstart's platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small-dollar loans.